AKBA earnings: a negative outcome, -9.0%

On November 4, 2021, Akebia Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -9.0% in the window around the event. It had already run +12.2% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.